Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 14, 2026
April 14, 2026
8bd86906-9b70-4e40-ae4a-dde0c1ea99ca
Related Documents
Potency Assessment of Active Immunotherapy Products
Guidance DocumentAugust 19, 2026Center for Biologics Evaluation and Research
Expedited Programs for Regenerative Medicine Therapies for Serious Conditions: Draft Guidance for Industry
Guidance DocumentSeptember 24, 2025Center for Biologics Evaluation and Research
Potency Assurance for Cellular and Gene Therapy Products
Guidance DocumentDecember 27, 2023Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.